Skin autofluorescence is associated with the progression of chronic kidney disease: A prospective observational study

PLoS ONE

Volumn 8, Issue 12, 2013, Pages

  Tanaka, Kenichi ^a   Nakayama, Masaaki ^a   Kanno, Makoto ^a   Kimura, Hiroshi ^a   Watanabe, Kimio ^a   Tani, Yoshihiro ^a   Kusano, Yuki ^a   Suzuki, Hodaka ^a   Hayashi, Yoshimitsu ^a   Asahi, Koichi ^a   Sato, Keiji ^b   Miyata, Toshio ^c   Watanabe, Tsuyoshi ^a  

^a FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

^b Department of Nephrology   (Japan)

^c TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED GLYCATION END PRODUCT; CREATININE;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CHRONIC KIDNEY DISEASE; COHORT ANALYSIS; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CUTANEOUS PARAMETERS; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HEMODIALYSIS PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PROGNOSIS; PROSPECTIVE STUDY; PROTEINURIA; REFERENCE VALUE; RISK ASSESSMENT; SEX RATIO; SKIN AUTOFLUORESCENCE; SMOKING; TISSUE LEVEL;

ADULT; AGED; DISEASE PROGRESSION; FEMALE; FLUORESCENCE; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RENAL INSUFFICIENCY, CHRONIC; SKIN; TIME FACTORS;

EID: 84892593913     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0083799     Document Type: Article

References (35)

1. Miyata T, Fu MX, Kurokawa K, van Ypersele de Strihou C, Thorpe SR, et al. (1998) Autoxidation products of both carbohydrates and lipids are increased in uremic plasma: is there oxidative stress in uremia? Kidney Int 54: 1290-1295.
2. Miyata T, Kurokawa K (1999) Carbonyl stress: increased carbonyl modification of proteins by autoxidation products of carbohydrates and lipids in uremia. Int J Artif Organs 22: 195-198.
3. Miyata T, Ueda Y, Shinzato T, Iida Y, Tanaka S, et al. (1996) Accumulation of albumin-linked and free-form pentosidine in the circulation of uremic patients with end-stage renal failure: renal implications in the pathophysiology of pentosidine. J Am Soc Nephrol 7: 1198-1206.
4. Miyata T, Wada Y, Cai Z, Iida Y, Horie K, et al. (1997) Implication of an increased oxidative stress in the formation of advanced glycation end products in patients with end-stage renal failure. Kidney Int 51: 1170-1181.
5. Nishikawa T, Edelstein D, Du XL, Yamagishi S, Matsumura T, et al. (2000) Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature 404: 787-790.
6. Aronson D (2003) Cross-linking of glycated collagen in the pathogenesis of arterial and myocardial stiffening of aging and diabetes. J Hypertens 21: 3-12.
7. Tanji N, Markowitz GS, Fu C, Kislinger T, Taguchi A, et al. (2000) Expression of advanced glycation end products and their cellular receptor RAGE in diabetic nephropathy and nondiabetic renal disease. J Am Soc Nephrol 11: 1656-1666.
8. Meerwaldt R, Graaff R, Oomen PH, Links TP, Jager JJ, et al. (2004) Simple non-invasive assessment of advanced glycation endproduct accumulation. Diabetologia 47: 1324-1330.
9. Meerwaldt R, Hartog JW, Graaff R, Huisman RJ, Links TP, et al. (2005) Skin autofluorescence, a measure of cumulative metabolic stress and advanced glycation end products, predicts mortality in hemodialysis patients. J Am Soc Nephrol 16: 3687-3693.
10. Meerwaldt R, Links T, Graaff R, Thorpe SR, Baynes JW, et al. (2005) Simple noninvasive measurement of skin autofluorescence. Ann N Y Acad Sci 1043: 290-298.
11. Meerwaldt R, Lutgers HL, Links TP, Graaff R, Baynes JW, et al. (2007) Skin autofluorescence is a strong predictor of cardiac mortality in diabetes. Diabetes Care 30: 107-112.
12. Tanaka K, Tani Y, Asai J, Nemoto F, Kusano Y, et al. (2011) Skin autofluorescence is associated with renal function and cardiovascular diseases in pre-dialysis chronic kidney disease patients. Nephrol Dial Transplant 26: 214-220.
13. McIntyre NJ, Fluck RJ, McIntyre CW, Taal MW (2011) Skin autofluorescence and the association with renal and cardiovascular risk factors in chronic kidney disease stage 3. Clin J Am Soc Nephrol 6: 2356-2363.
14. Yue X, Hu H, Koetsier M, Graaff R, Han C (2011) Reference values for the Chinese population of skin autofluorescence as a marker of advanced glycation end products accumulated in tissue. Diabet Med 28: 818-823.
15. Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, et al. (2009) Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis 53: 982-992.
16. Schwedler SB, Metzger T, Schinzel R, Wanner C (2002) Advanced glycation end products and mortality in hemodialysis patients. Kidney Int 62: 301-310.
17. Mulder DJ, Water TV, Lutgers HL, Graaff R, Gans RO, et al. (2006) Skin autofluorescence, a novel marker for glycemic and oxidative stress-derived advanced glycation endproducts: an overview of current clinical studies, evidence, and limitations. Diabetes Technol Ther 8: 523-535.
18. de Zeeuw D, Remuzzi G, Parving HH, Keane WF, Zhang Z, et al. (2004) Proteinuria, a target for renoprotection in patients with type 2 diabetic nephropathy: lessons from RENAAL. Kidney Int 65: 2309-2320.
19. Keane WF, Brenner BM, de Zeeuw D, Grunfeld JP, McGill J, et al. (2003) The risk of developing end-stage renal disease in patients with type 2 diabetes and nephropathy: the RENAAL study. Kidney Int 63: 1499-1507.
20. Brownlee M (2005) The pathobiology of diabetic complications: a unifying mechanism. Diabetes 54: 1615-1625.
21. Ramasamy R, Vannucci SJ, Yan SS, Herold K, Yan SF, et al. (2005) Advanced glycation end products and RAGE: a common thread in aging, diabetes, neurodegeneration, and inflammation. Glycobiology 15: 16R-28R.
22. Gerrits EG, Lutgers HL, Kleefstra N, Graaff R, Groenier KH, et al. (2008) Skin autofluorescence: a tool to identify type 2 diabetic patients at risk for developing microvascular complications. Diabetes Care 31: 517-521.
23. Tanaka K, Tani Y, Asai J, Nemoto F, Kusano Y, et al. (2012) Skin autofluorescence is associated with severity of vascular complications in Japanese patients with Type 2 diabetes. Diabet Med 29: 492-500.
24. Daroux M, Prevost G, Maillard-Lefebvre H, Gaxatte C, D'Agati VD, et al. (2010) Advanced glycation end-products: implications for diabetic and nondiabetic nephropathies. Diabetes Metab 36: 1-10.
25. Zhou LL, Cao W, Xie C, Tian J, Zhou Z, et al. (2012) The receptor of advanced glycation end products plays a central role in advanced oxidation protein products-induced podocyte apoptosis. Kidney Int 82: 759-770.
26. Gerrits EG, Smit AJ, Bilo HJ (2009) AGEs, autofluorescence and renal function. Nephrol Dial Transplant 24: 710-713.
27. Na R, Stender IM, Henriksen M, Wulf HC (2001) Autofluorescence of human skin is age-related after correction for skin pigmentation and redness. J Invest Dermatol 116: 536-540.
28. Matsumoto T, Tsurumoto T, Baba H, Osaki M, Enomoto H, et al. (2007) Measurement of advanced glycation endproducts in skin of patients with rheumatoid arthritis, osteoarthritis, and dialysis-related spondyloarthropathy using non-invasive methods. Rheumatol Int 28: 157-160.
29. Ohnuki Y, Nagano R, Takizawa S, Takagi S, Miyata T (2009) Advanced glycation end products in patients with cerebral infarction. Intern Med 48: 587-591.
30. Tanaka K, Katoh T, Asai J, Nemoto F, Suzuki H, et al. (2010) Relationship of skin autofluorescence to cardiovascular disease in Japanese hemodialysis patients. Ther Apher Dial 14: 334-340.
31. Ueno H, Koyama H, Fukumoto S, Tanaka S, Shoji T, et al. (2011) Advanced glycation end products, carotid atherosclerosis, and circulating endothelial progenitor cells in patients with end-stage renal disease. Metabolism 60: 453-459.
32. Ueno H, Koyama H, Tanaka S, Fukumoto S, Shinohara K, et al. (2008) Skin autofluorescence, a marker for advanced glycation end product accumulation, is associated with arterial stiffness in patients with end-stage renal disease. Metabolism 57: 1452-1457.
33. Coughlan MT, Forbes JM, Cooper ME (2007) Role of the AGE crosslink breaker, alagebrium, as a renoprotective agent in diabetes. Kidney Int Suppl: S54-60.
34. Forbes JM, Thallas V, Thomas MC, Founds HW, Burns WC, et al. (2003) The breakdown of preexisting advanced glycation end products is associated with reduced renal fibrosis in experimental diabetes. FASEB J 17: 1762-1764.
35. Joshi D, Gupta R, Dubey A, Shiwalkar A, Pathak P, et al. (2009) TRC4186, a novel AGE-breaker, improves diabetic cardiomyopathy and nephropathy in Ob-ZSF1 model of type 2 diabetes. J Cardiovasc Pharmacol 54: 72-81.